Stempeutics Gets Stem Cell Patent in China (Chinese Application Number … – PR Newswire (press release)
|
Stempeutics Gets Stem Cell Patent in China (Chinese Application Number …
PR Newswire (press release) Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the State Intellectual Property Office of China (SIPO) granted a process patent for its novel stem–cell based drug … |
